Thus, we propose that cleavage and removal of versican blockades via the action of proteoglycanases, such as ADAMTS5, is required for efficient T cell interaction with the ECM to encourage migration to effector sites in the periphery and for the subsequent resolution of infection (Fig 8G). The gene discussed is ADAMTS5; the disease is infection.